Cited by 375interferon and immune responsesRNA and protein synthesis mechanismsHIV Research and Treatment

Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11

Open access
Li, Manqing, Kao, Elaine, Gao, Xia, Sandig, Hilary, Limmer, Kirsten, Pavon-Eternod, Mariana, Jones, Thomas E., Landry, Sebastien +3 more·2012·Nature

Abstract

In mammals, one of the most pronounced consequences of viral infection is the induction of type I interferons, cytokines with potent antiviral activity. Schlafen (Slfn) genes are a subset of interferon-stimulated early response genes (ISGs) that are also induced directly by pathogens via the interferon regulatory factor 3 (IRF3) pathway. However, many ISGs are of unknown or incompletely understood function. Here we show that human SLFN11 potently and specifically abrogates the production of retroviruses such as human immunodeficiency virus 1 (HIV-1). Our study revealed that SLFN11 has no effect on the early steps of the retroviral infection cycle, including reverse transcription, integration and transcription. Rather, SLFN11 acts at the late stage of virus production by selectively inhibiting the expression of viral proteins in a codon-usage-dependent manner. We further find that SLFN11 binds transfer RNA, and counteracts changes in the tRNA pool elicited by the presence of HIV. Our studies identified a novel antiviral mechanism within the innate immune response, in which SLFN11 selectively inhibits viral protein synthesis in HIV-infected cells by means of codon-bias discrimination.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nature11433

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Of the five human Schlafen isoforms, two (Schlafen 11 and Schlafen 13) were identified as inhibitory factors for HIV-1.

    “Of the five human Schlafen isoforms, two (Schlafen 11 and Schlafen 13) were identified as inhibitory factors for HIV-1 (106, 108).”

    From Role of host tRNAs and aminoacyl-tRNA synthetases in retroviral replication (2019) · cites this paper as [106]

    The paper reports that SLFN11 inhibits HIV-1 production, supporting one of the two named factors. It does not identify SLFN13 as an HIV-1 inhibitory factor, and its introductory passage says there are six human SLFN genes, not five (both passages are labeled Abstract in our copy; no page is given). (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Schlafen 11 expression is induced by interferon, whereas Hili expression is a result of T-cell activation.

    “Although there appears to be high similarity between Hili-and Schlafen 11-mediated inhibition of HIV-1, Schlafen 11 expression is induced by interferon, whereas Hili expression is a result of T-cell activation (106, 114).”
  • Human Schlafen 11 protein inhibits HIV-1 gene expression via intrinsic properties of the transcripts.

    “Indeed, the human Schlafen 11 protein was reported to inhibit HIV-1 gene expression via intrinsic properties of the transcripts (106).”
  • Human Schlafen 11 binds to tRNAs and selectively inhibits HIV-1 gene expression in a codon usage-based manner.

    “Human Schlafen 11, a putative DNA/RNA helicase with regulatory roles in cancer cell lines (109 -111), binds to tRNAs and selectively inhibits HIV-1 gene expression in a codon usage-based manner (106).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

No references could be resolved yet.

Research works printed but not linked: 28

  1. [1]Sohn WJ Novel transcriptional regulation of the schlafen-2 gene in macrophages in response to TLR-triggered stimulation Mol Immunol 44 3273 3282 2007 17434208
  2. [2]Yoneyama M Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity J Immunol 175 2851 2858 2005 16116171
  3. [3]Schwarz DA Katayama CD Hedrick SM Schlafen, a new family of growth regulatory genes that affect thymocyte development Immunity 9 657 668 1998 9846487
  4. [4]Geserick P Kaiser F Klemm U Kaufmann SH Zerrahn J Modulation of T cell development and activation by novel members of the Schlafen (slfn) gene family harbouring an RNA helicase-like motif Int Immunol 16 1535 1548 2004 15351786
  5. [5]Berger M An Slfn2 mutation causes lymphoid and myeloid immunodeficiency due to loss of immune cell quiescence Nature Immunol 11 335 343 2010 20190759 PMC2861894
  6. [6]Fritz CC Green MR HIV Rev uses a conserved cellular protein export pathway for the nucleocytoplasmic transport of viral RNAs Curr Biol 6 848 854 1996 8805303
  7. [7]Fischer U Huber J Boelens WC Mattaj IW Luehrmann R The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs Cell 82 475 483 1995 7543368
  8. [8]Malim MH Hauber J Le SY Maizel JV Cullen BR The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA Nature 338 254 257 1989 2784194
  9. [9]Van Damme N The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein Cell Host Microbe 3 245 252 2008 18342597 PMC2474773
  10. [10]Neil SJ Zang T Bieniasz PD Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu Nature 451 425 430 2008 18200009
  11. [11]Ganser-Pornillos BK Yeager M Sundquist WI The structural biology of HIV assembly Curr Opin Struct Biol 18 203 217 2008 18406133 PMC2819415
  12. [12]Coleman JR Virus attenuation by genome-scale changes in codon pair bias Science 320 1784 1787 2008 18583614 PMC2754401
  13. [13]Zhou T Gu W Ma J Sun X Lu Z Analysis of synonymous codon usage in H5N1 virus and other influenza A viruses Biosystems 81 77 86 2005 15917130
  14. [14]Meintjes PL Rodrigo AG Evolution of relative synonymous codon usage in human immunodeficiency virus type-1 J Bioinform Comput Biol 3 157 168 2005 15751118
  15. [15]Frelin L Codon optimization and mRNA amplification effectively enhances the immunogenicity of the hepatitis C virus nonstructural 3/4A gene Gene Ther 11 522 533 2004 14999224
  16. [16]Forsberg R Christiansen FB A codon-based model of host-specific selection in parasites, with an application to the influenza A virus Mol Biol Evol 20 1252 1259 2003 12777510
  17. [17]Plotkin JB Dushoff J Codon bias and frequency-dependent selection on the hemagglutinin epitopes of influenza A virus Proc Natl Acad Sci USA 100 7152 7157 2003 12748378 PMC165845
  18. [18]Grantham P Perrin P AIDS virus and HTLV-I differ in codon choices Nature 319 727 728 1986 3005869
  19. [19]Wong EHM Smith DK Rabadan R Peiris M Poon LLM Codon usage bias and the evolution of influenza A viruses. Codon usage biases of influenza virus BMC Evol Biol 10 253 2010 20723216 PMC2933640
  20. [20]van Weringh A HIV-1 modulates the tRNA pool to improve translation efficiency Mol Biol Evol 28 1827 1834 2011 21216840 PMC3098512
  21. [21]Kofman A HIV-1 gag expression is quantitatively dependent on the ratio of native and optimized codons Tsitologiia 45 86 93 2003 12683241
  22. [22]Haas J Park EC Seed B Codon usage limitation in the expression of HIV-1 envelope glycoprotein Curr Biol 6 315 324 1996 8805248
  23. [23]Berkhout B van Hemert FJ The unusual nucleotide content of the HIV RNA genome results in a biased amino acid composition of HIV proteins Nucleic Acids Res 22 1705 1711 1994 8202375 PMC308053
  24. [24]Kypr J Mrazek J Unusual codon usage of HIV Nature 327 20 1987 3646480
  25. [25]Pavon-Eternod M tRNA over-expression in breast cancer and functional consequences Nucleic Acids Res 37 7268 7280 2009 19783824 PMC2790902
  26. [26]Dittmar KA Mobley EM Radek AJ Pan T Exploring the regulation of tRNA distribution on the genomic scale J Mol Biol 337 31 47 2004 15001350
  27. [27]Coccia EM Krust B Hovanessian AG Specific inhibition of viral protein synthesis in HIV-infected cells in response to interferon treatment J Biol Chem 269 23087 23094 1994 7521875
  28. [28]Connor RI Chen BK Choe S Landau NR Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes Virology 206 935 944 1995 7531918

Cited by

Sorted by citations

Authors
Li, M., Kao, E., Gao, X., Sandig, H., Limmer, K., Pavon-Eternod, M., Jones, T. E., Landry, S., Pan, T., Weitzman, M. D., & David, M.
Affiliations
  • University of California San Diego (US)
  • University of Chicago (US)
  • Salk Institute for Biological Studies (US)
Corresponding author
David, Michael
Venue
Nature
Published
2012-09-23
Volume
491
Issue
7422
Pages
125-128
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1974786493
Cited by
375
References
0
Citations by year
2026: 18 · 2025: 32 · 2024: 34 · 2023: 34 · 2022: 20 · 2021: 36 · 2020: 20 · 2019: 33 · 2018: 27 · 2017: 28 · 2016: 16 · 2015: 24 · 2014: 25 · 2013: 23 · 2012: 5
FWCI
10.77
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Institute of General Medical Sciences (R01GM101982)
  • National Institute of Allergy and Infectious Diseases (P30AI 36214, P01AI090935, AI074967, R21AI088490, R01AI074967, R21AI081019, P30AI036214, AI81019)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA and protein synthesis mechanisms
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
Keywords
Schlafen 11, SLFN11, HIV-1, codon usage bias, tRNA binding, antiviral innate immunity, interferon-stimulated genes, rare codons, viral protein synthesis inhibition, type I interferon, retroviral infection
MeSH terms
Cell Line, Cells, Cultured, Codon, Humans, Immunity, Innate, Nuclear Proteins, RNA, Transfer, RNA, Viral, Species Specificity, Substrate Specificity, Protein Biosynthesis, Viral Proteins, HIV-1, Gene Expression Regulation, Viral, Virus Integration, Reverse Transcription, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review